Clovis Oncology Inc (fka CLVSQ) (CLVSQ)

[Trend-Setter]

Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3.5 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.

**************** Upward Growth *****************
-FY- ------------------ Revenue ---------------------------------Net Income
2019 ----------------7,568,508----------------------------------- (9,279,321)
2020 ---------------17,994,639----------------------------------- (2,240,351)
2021--------------- 25,380,749------------------------------------ 5,088,421
2022--------------- 32,262,117------------------------------------ 8,898,245
All in the company SEC filings

Outstanding Shares: 1.01 Billion
Float : ~ 750 Million

Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm

ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?

Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall

>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.